# Agenus Inc: filings

AGEN · Nasdaq · CIK 1098972 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agen.md) · [Financials](/companies/agen/financials.md) · [Filings](/companies/agen/filings.md) · [Insiders](/companies/agen/insiders.md)

## Reports and events: 396 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 881, 8-K 290, 424B3 205, SC 13G/A 58, 10-Q 53, CT ORDER 35, CORRESP 31, UPLOAD 30, 4/A 28, EFFECT 28, SC 13G 23, 3 22, S-3 22, DEF 14A 20, S-8 20, 10-K 18, 424B5 13, D 11, PRE 14A 11, POS AM 8, DEFA14A 7, S-3/A 5, S-3ASR 5, 8-K/A 4, ARS 4, SCHEDULE 13G/A 4, S-1/A 3, SCHEDULE 13G 3, 10-K/A 2, 5 2, DEFR14A 2, S-1 2, SC 13D/A 2, 144 1, POSASR 1, RW 1, SC 13D 1, SCHEDULE 13D 1, SC TO-C 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-18 | 20:30 ET | [8-K](/filings/0001193125-26-355559.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-26-355559 |
| 2026-08-13 | 01:30 ET | [8-K](/filings/0001193125-26-347518.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-347518 |
| 2026-08-11 | 20:30 ET | [8-K](/filings/0001193125-26-344783.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-344783 |
| 2026-08-07 | 20:30 ET | [10-Q](/filings/0001193125-26-340363.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340363 |
| 2026-08-06 | 11:52 ET | [8-K](/filings/0001193125-26-336780.md) | 2.02 Results of operations | 0001193125-26-336780 |
| 2026-07-13 | 10:30 ET | [8-K](/filings/0001193125-26-301414.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301414 |
| 2026-07-06 | 20:10 ET | [8-K](/filings/0001193125-26-296186.md) | 1.01 Entry into a material agreement | 0001193125-26-296186 |
| 2026-06-23 | 14:14 ET | [8-K](/filings/0001193125-26-278647.md) | 5.07 Shareholder vote results | 0001193125-26-278647 |
| 2026-05-15 | 20:08 ET | [8-K](/filings/0001193125-26-226693.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-226693 |
| 2026-05-11 | 21:04 ET | [10-Q](/filings/0001193125-26-217082.md) | Quarterly report, period 2026-03-31 | 0001193125-26-217082 |
| 2026-05-11 | 12:52 ET | [8-K](/filings/0001193125-26-215838.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-215838 |
| 2026-04-30 | 20:34 ET | [DEF 14A](/filings/0001193125-26-197536.md) | Proxy statement, period 2026-04-30 | 0001193125-26-197536 |
| 2026-03-26 | 12:24 ET | [8-K](/filings/0001193125-26-125170.md) | 8.01 Other events | 0001193125-26-125170 |
| 2026-03-16 | 21:19 ET | [10-K](/filings/0001193125-26-108632.md) | Annual report, period 2025-12-31 | 0001193125-26-108632 |
| 2026-03-16 | 12:15 ET | [8-K](/filings/0001193125-26-107288.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-107288 |
| 2026-01-23 | 13:57 ET | [SCHEDULE 13D](/filings/0002106704-26-000001.md) | Ownership report, active investor | 0002106704-26-000001 |
| 2026-01-16 | 13:25 ET | [8-K](/filings/0001193125-26-014678.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-014678 |
| 2026-01-14 | 21:09 ET | [8-K](/filings/0001193125-26-012922.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-012922 |
| 2026-01-08 | 21:13 ET | [8-K](/filings/0001193125-26-007706.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights | 0001193125-26-007706 |
| 2025-11-10 | 22:12 ET | [10-Q](/filings/0001193125-25-274554.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274554 |
| 2025-11-10 | 12:32 ET | [8-K](/filings/0001193125-25-273266.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273266 |
| 2025-10-09 | 20:05 ET | [8-K](/filings/0001193125-25-235819.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-235819 |
| 2025-09-23 | 21:12 ET | [8-K](/filings/0001193125-25-213574.md) | 8.01 Other events | 0001193125-25-213574 |
| 2025-08-11 | 20:55 ET | [10-Q](/filings/0000950170-25-106633.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106633 |
| 2025-08-11 | 11:31 ET | [8-K](/filings/0000950170-25-106235.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106235 |
| 2025-06-20 | 20:10 ET | [8-K](/filings/0000950170-25-088502.md) | 5.07 Shareholder vote results | 0000950170-25-088502 |
| 2025-06-04 | 20:37 ET | [8-K](/filings/0000950170-25-081674.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081674 |
| 2025-05-12 | 20:50 ET | [10-Q](/filings/0000950170-25-069396.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069396 |
| 2025-05-12 | 11:32 ET | [8-K](/filings/0000950170-25-068564.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068564 |
| 2025-04-30 | 20:05 ET | [DEF 14A](/filings/0000950170-25-061030.md) | Proxy statement, period 2025-04-30 | 0000950170-25-061030 |
| 2025-03-17 | 20:16 ET | [10-K](/filings/0000950170-25-040289.md) | Annual report, period 2024-12-31 | 0000950170-25-040289 |
| 2025-03-11 | 11:35 ET | [8-K](/filings/0000950170-25-036829.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036829 |
| 2025-02-26 | 22:21 ET | [8-K](/filings/0000950170-25-027947.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-027947 |
| 2025-02-10 | 21:05 ET | [8-K](/filings/0000950170-25-017028.md) | 1.02 Termination of a material agreement | 0000950170-25-017028 |
| 2024-12-05 | 12:35 ET | [8-K](/filings/0000950170-24-133532.md) | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-24-133532 |
| 2024-11-27 | 13:39 ET | [8-K](/filings/0000950170-24-131263.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-131263 |
| 2024-11-12 | 21:58 ET | [10-Q](/filings/0000950170-24-125608.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125608 |
| 2024-11-12 | 12:05 ET | [8-K](/filings/0000950170-24-124543.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124543 |
| 2024-11-08 | 21:05 ET | [8-K/A](/filings/0000950170-24-124055.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-124055 |
| 2024-11-05 | 21:05 ET | [8-K](/filings/0000950170-24-121443.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-121443 |
| 2024-08-08 | 20:49 ET | [8-K](/filings/0001193125-24-197046.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197046 |
| 2024-08-08 | 20:08 ET | [10-Q](/filings/0000950170-24-093937.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093937 |
| 2024-08-02 | 20:02 ET | [8-K](/filings/0000950170-24-089932.md) | 1.02 Termination of a material agreement | 0000950170-24-089932 |
| 2024-06-17 | 20:05 ET | [8-K](/filings/0000950170-24-074231.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-074231 |
| 2024-06-14 | 20:02 ET | [8-K](/filings/0000950170-24-073614.md) | 5.07 Shareholder vote results | 0000950170-24-073614 |
| 2024-05-30 | 20:01 ET | [8-K](/filings/0000950170-24-066545.md) | 2.01 Completion of an acquisition or disposition | 0000950170-24-066545 |
| 2024-05-07 | 11:39 ET | [8-K](/filings/0000950170-24-053952.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053952 |
| 2024-05-07 | 11:38 ET | [10-Q](/filings/0000950170-24-053951.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053951 |
| 2024-05-07 | 11:31 ET | [8-K](/filings/0000950170-24-053949.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-053949 |
| 2024-04-26 | 16:28 ET | [DEF 14A](/filings/0000950170-24-048786.md) | Proxy statement, period 2024-06-11 | 0000950170-24-048786 |

Page 1 of 8. [Older](/companies/agen/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.